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Summary Matrix vesicle-mediated mineralization is an orchestrated sequence of ultrastruc-
tural and biochemical events that lead to crystal nucleation and growth. The influx of phosphate
ions into the matrix vesicle is mediated by several proteins such as TNAP, ENPP1, Pit1, annexin
and so forth. The catalytic activity of ENPP1 generates pyrophosphate (PPi) using extracel-
lular ATPs as a substrate, and the resultant PPi prevents crystal overgrowth. However, TNAP
hydrolyzes PPi into phosphate ion monomers, which are then transported into the matrix
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vesicle through Pit1. Accumulation of Ca2+ and PO43− inside matrix vesicles then induces crys-
talline nucleation, with calcium phosphate crystals budding off radially, puncturing the matrix
vesicle’s membrane and finally growing out of it to form mineralized nodules.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of Japanese Association for Dental
Science. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
C
1
B
p
l
t
i
a
m
g
T
fi
I
w
m
i
m
a
m
t
a
o
r
b
a
t
b
m
a
H
u
b
t
t
aorg/licenses/by-nc-nd/4.0/).
ontents
1. Introduction ............................................................................................................... 00
2. Ultrastructural aspects of matrix vesicle-mediated mineralization in bone ................................................ 00
2.1. Ultrastructural properties of the matrix vesicles under electron microscopy ........................................00
2.2. Mineralized nodules developed from matrix vesicles ................................................................00
3. Enzymes and membrane transporter are necessary for matrix vesicle-mediated mineralization in bone ................... 00
3.1. Biological function of tissue nonspecific alkaline phosphatase (TNAP) in matrix vesicle-mediated mineralization ... 00
3.2. Biological action of ecto-nucleotide pyrophosphatase/phosphodiesterase 1, ENPP 1 in bone mineralization ........ 00
3.3. Putative function of ankylosis protein (ANK) in pyrophosphate transport in cells ....................................00
3.4. Ca2+ transport through annexins .................................................................................... 00
4. Ultrastructure of collagen mineralization..................................................................................00
5. Concluding remarks........................................................................................................00
Conflict of interest ........................................................................................................ 00
Acknowledgments ......................................................................................................... 00
References ................................................................................................................ 00
. Introduction
one is a living mineralized tissue composed of calcium
hosphates and a variety of organic materials, with col-
agen being the most abundant. Bone mineralization has
wo phases: primary and secondary. Primary mineralization
s orchestrated by osteoblasts; osteoblasts secret a large
mount of collagen fibrils, non-collagenous proteins, and
atrix vesicles, which are extracellular vesicles that trig-
er mineralization viamembrane transporters and enzymes.
he degree of the primary mineralization is controlled by
ne-tuning bone formation and mineral apposition rates.
n contrast, secondary mineralization is a phenomenon
hereby there is a gain in bonemineral density after primary
ineralization. It is hypothesized that secondary mineral-
zation is regulated physicochemically, i.e., through crystal
aturation, and by the osteocytic network inside the miner-
lized bone matrix. Still, the mechanisms behind secondary
ineralization are relatively untapped.
In bone, primary mineralization can be divided into
wo phases: first, matrix vesicle-mediated mineralization,
nd second, collagen mineralization. During the process
f the matrix vesicle-mediated mineralization, osteoblasts
egulate vesicle synthesis as well as the activity of mem-
rane transporters and enzymes with which matrix vesicles
re equipped. Discovery of matrix vesicles was a break-
hrough in the field of bone mineralization [1—7]. Long
efore that, it was proposed that alkaline phosphatase
ay supply phosphates by hydrolyzing phosphate substrates
nd then help forming crystalline calcium phosphates [8].
owever, this theory is based on the physicochemical reg-
lation of bone mineralization. In contrast, the theory
of the ultrastructure and biological activities of membrane
transporters/enzymes may clarify the cellular mechanisms
of matrix vesicle-mediated mineralization and explain, for
instance, why mineral appositional rate is higher in regions
of accelerated bone turnover.
In this review, we will present the ultrastructural and bio-
chemical aspects of matrix vesicle-mediated mineralization
in bone.
2. Ultrastructural aspects of matrix
vesicle-mediated mineralization in bone
Matrix vesicles are extracellular vesicles enveloped by
a plasma membrane (ranging 30—1000 nm in diameter)
secreted by osteoblasts [2] (Fig. 1). Matrix vesicles bear
several membrane transporters and enzymes on their
membranes and in their interior, providing a nurturing
microenvironment for calcium phosphate nucleation and
subsequent crystal growth. Mineralization begins when
a crystalline calcium phosphate, i.e., hydroxyapatite
[Ca10(PO4)6(OH)2], appears inside the matrix vesicles, grow-
ing and eventually breaking through the vesicle’s membrane
to form mineralized nodules—–also known as calcifying glob-
ules (Figs. 1 & 2). Under transmission electron microscopy
(TEM), each hydroxyapatite crystal has a small, ribbon-like
structure profile approximately 25 nm wide, 10 nm high and
50 nm long [9,10].
2.1. Ultrastructural properties of the matrix
vesicles under electron microscopy
Some of these incipient mineral crystals were initially foundPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
ehind matrix vesicle-mediated mineralization sustains that
he processes are mainly under the control of osteoblasts
hrough the regulation of membrane transporters/enzymes
nd surrounding extracellular organic materials. Knowledge
a
b
btural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
ssociated with the inner leaflet of the matrix vesicle mem-
ranes, and it seems plausible that crystal nucleation would
egin at that specific site. Matrix vesicle membranes are
Please cite this article in press as: Hasegawa T, et al. Ultrastructural and biochemical aspects of matrix vesicle-mediated
mineralization. Japanese Dental Science Review (2016), http://dx.doi.org/10.1016/j.jdsr.2016.09.002
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Figure 1 TEM observation of matrix vesicles and mineralized nodules in osteoid.
(A) TEM image of ultratrsucture of osteoid underlying mature osteoblasts (OB). Notice many mineralized globular structures referred
to as mineralized nodule (MN) in the osteoid. (B—E) TEM images of matrix vesicles (MV) (B), appearance of mineral crystals in the
matrix vesicles (C), exposure of mineral crystals out of the matrix vesicles (D) and mineralized nodule (MN) formation (E). An inset
demonstrate a highly-magnified image of needle-shape of mineral crystals.
Panel A is derived from Ref. [71] (Amizuka and Ozawa), while panels B—F are modified from Ref. [72] (Amizuka et al.).
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Figure 2 Highly-magnified images of matrix vesicles and elemental mapping of calcium and phosphate ions.
(A—C) TEM images of matrix vesicles (MV). (A) amorphous electron-dense structure (double arrows, black) are shown to be associated
with plasma membrane of the matrix vesicle. (B) The grown mineral crystals (black structures) are seen inside the matrix vesicles.
(C) Mineral crystals are getting out of the matrix vesicles. (D—F) TEM image (D) and elemental mapping of calcium (Ca, panel E)
and phosphorus (P, panel F) assessed by electron energy loss spectroscopy. Note that calcium (Ca) was evenly distributed in the
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oeripheral region of matrix vesicles, while phosphorus (P) is pre
he images of A—C are modified from Ref. [73] (Ozawa et al.),
ich in acidic phospholipids such as phosphatidylserine and
hosphatidylinositol, which have high affinity for Ca2+. The
ffinity of phosphatidylserine for Ca2+ is particularly high
nd can produce a stable calcium phosphate—phospholipid
omplex associated with the inner leaflet of the vesicle’s
embrane [7] (Fig. 2A). The possibility that such complexes
ay play an important role in crystal nucleation has been
ointed out before [11,12]. However, the early phases of
alcium phosphate nucleation inside the matrix vesicles may
e rather amorphous [13], but gradually become crystalline
hydroxyapatite) in later stages. Calcium phosphate crystals
ormed inside matrix vesicles can grow through the addi-
ion of Ca2+ and PO43−, which enter the vesicles through the
ction of membrane transporters and enzymes. Inside the
atrix vesicle, ‘‘needle-shaped’’ crystalline calcium phos-
hates form a stellate assembly, bud off radially from the
esicle’s interior, and then, rip through the plasma mem-
rane to form mineralized nodules, also referred to as
alcifying globules [6] (Figs. 1E and 2D). While the needle-
haped crystals are identified as crystalline structures by
lectron diffraction, freeze-substitution and cytochemical
alcium detection methods such as  -pyroantimonate com-
ined with energy-dispersive X-ray spectroscopy may show
hem as non-crystalline structures containing calcium andPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
hosphate [14—16].
According to observations of the osteoid in bone derived
rom the quick frozen-freeze substitution technique with
lectron energy loss spectroscopy, which enables elemen-
I
v
b
tinant in collagen fibrils.
D—F are from Ref. [17] (Hoshi et al.).
al mapping at the molecular level, calcium was evenly
istributed in the proteoglycan-rich, peripheral region of
atrix vesicles, whereas phosphate was detected predom-
nantly in collagen fibrils [17] (Fig. 2D—F). Therefore, it
eems feasible that, in non-calcified sites, the extracellu-
ar meshwork of organic substances limits the production of
ydroxyapatite and inhibits precipitation of calcified crys-
als by controlling the spatial distribution of Ca2+ and PO43−,
ven if the extracellular fluid is supersaturated with those
ons. In addition, a biological mechanism of PO43− supple-
entation and subsequent transport into matrix vesicles
ust be in place, since PO43− is not abundant in the periph-
ry of matrix vesicles. Later in the text, we will discuss
bout the biological actions of membrane transporters and
nzymes to produce PO43− and to warrant the influx of Ca2+
nd PO43− into the matrix vesicles.
.2. Mineralized nodules developed from matrix
esicles
atrix vesicles and developing mineralized nodules can be
bserved in the osteoid below mature osteoblasts (Fig. 1A).tural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
t seems that the osteoid provides an adequate microen-
ironment for the development of mineralized nodules in
one. Even though the vesicle’s membrane is ripped during
he process of crystal growth, the mineralized nodules might
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Figure 3 TEM observation on mineralized nodules of normal rats and warfarin-treated rats.
Panels A and C demonstrate the ultrastructure of mineralized nodules in the osteoid of normal and warfarin-administered rat
bones. In control group, globular mineralized nodules (MN) are shown to be composed of many needle-shaped mineral crystals (A).
However, the warfarin-administered osteoid shows dispersed mineral crystals throughout the osteoid (C). (B and D) Immunoelectron
microscopy for osteocalcin localization. Osteocalcin immunoreactivity (black particles) can be seen on the mineralized nodules (MN,
grey colored globular structures) of the control osteoid (B), while little immunoreactivity for osteocalcin is seen in the warfarin-
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eadministered osteoid (D).
The images are derived from Ref. [29] (Amizuka et al.).
retain the membrane-associated enzymes and transporters,
which will be mentioned later in this text.
Mineralized nodule is a globular assembly of numerous
needle-shaped mineral crystals that has been exposed to
extracellular environment (Fig. 1E). It seems likely that the
growth of mineralized nodules is regulated by a large num-
ber of extracellular organic materials in the osteoid. Among
them, osteopontin is especially suited to the task of regu-
lating mineralization, because it effectively inhibits apatite
formation and growth [18,19]. Osteopontin is localized in
the periphery of mineralized nodules, where it might act as a
blocker of excessive mineralization [20]. Since other organic
materials can combine with osteopontin [21], they can form
the so-called ‘‘crystal ghosts’’ [22—24]. Among these mate-
rials, osteocalcin is known for containing  -carboxyglutamic
acid and for their ability to bind to mineral crystals [25—27].
Warfarin, which is an inhibitor for  -carboxylation of glu-
tamine residues, induces an embryopathy consisting of nasal
hypoplasia, stippled epiphyses and distal extremity hypopla-Please cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
sia when given to women in the first trimester of pregnancy
[25,28]. In our observations, the administration of warfarin
resulted in the dispersion of numerous fragments of needle-
shaped crystal minerals throughout the osteoid [29] (Fig. 3).
(
(
a
mecently,  -carboxylase-deficient mice revealed the same
bnormality with disassembled, scattered crystal minerals
n bone [30]. Therefore, osteocalcin may play an important
ole in the globular assembly of needle-shaped mineral crys-
als, probably binding the organic components of the crystal
heath together.
. Enzymes and membrane transporter are
ecessary for matrix vesicle-mediated
ineralization in bone
everal enzymes and proteins found in the matrix vesi-
les are involved in the metabolism of proteoglycans and
yrophosphate. Among these enzymes and membrane trans-
orters, tissue nonspecific alkaline phosphatase (TNAP),
cto-nucleotide pyrophosphatase/phosphodiesterase 1tural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
ENPP1), and others, e.g., annexin and ankylin protein
ANK) and sodium/phosphate co-transporter type III (Pit1)
ppear to a play pivotal role in matrix vesicle-mediated
ineralization.
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Figure 4 Histochemical localization of alkaline phosphatase in bone. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
(A and B) Enzyme histochemistry of alkaline phosphatase (ALPase, red color) and tissue nonspecific ALPase (TNAP, brown color)
immunohistochemistry. Both histochemical technique consistently reveal an intense enzymatic activity of ALPase and immunoreac-
tivity of TNAP in the regions of perosteoblasts (arrows, in A and B), rather than mature osteoblast (OB) located on bone matrix (BM).
(C) TEM image of ALPase enzyme cytochemistry. Note the ALPase activity (black) can be seen on cell membranes of preosteoblasts
(pre-OB) and mature osteoblasts (OB) on the bone surfaces. Insets demonstrate the ALPase enzyme activity on matrix vesicle (MV)
a CN).
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anels A and B are derived from Ref. [72] (Amizuka et al.), whi
.1. Biological function of tissue nonspecific
lkaline phosphatase (TNAP) in matrix
esicle-mediated mineralization
ne of the most important enzymes to initiate miner-
lization in bone is TNAP, a glycosylphosphatidylinositol
nchor enzyme associated with cell membranes (Fig. 4).
NAP can hydrolyze various phosphate esters, especially
yrophosphate (PPi), and is responsible for the production of
norganic phosphate, i.e., TNAP serve as pyrophosphatase to
enerate PO 3− monomer. The resultant PO 3− is transportedPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
4 4
nto the matrix vesicles by means of sodium/phosphate co-
ransporter type III (Pit1). Therefore, many believe TNAP is
potent inducer of mineralization.
o
o
f
tnel C is from Ref. [71] (Amizuka and Ozawa).
In bone, TNAP activity has been detected on osteoblasts
nd matrix vesicles [31,32]. Interestingly, the distribution of
NAP on the cell membrane is not uniform in osteoblasts,
hich reflect the cell polarity with distinct basolateral
nd secretory (osteoidal) domains (Fig. 4). It has been
eported that the plasma membrane Ca2+ transport ATPase
as restricted to the osteoidal domain of the osteoblas-
ic cell membrane, while TNAP was predominantly present
n the basolateral domain [33]. Consistently, using spe-
ific antiserum to TNAP [34], we could observe relatively
ntense immunoreactivity and enzymatic activity for TNAPtural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
n preosteoblasts and on the basolateral aspect of mature
steoblasts’ membranes [35]. Thus, in bone, the membranes
eaturing intense activity of TNAP are not identical to those
hat serve as sites for matrix vesicle formation, for matrix
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vesicles derive from the secretory (osteoidal) cell membrane
of osteoblasts—–which show weak TNAP enzymatic activity.
While the actual reason for that difference is still a matter of
debate, it could be that high levels of TNAP activity in the
matrix vesicles would induce mineral crystals overgrowth
within the osteoid.
Mice homogyzous for Tnap gene depletion have been
generated [36,37] and mimic severe hypophosphatasia, indi-
cating that TNAP is likely involved in mineralization. While
TNAP might act as a pyrophosphatase [38], other pyrophos-
phatases may exist. Tnap−/− mice are born with intact
bones, but gradually develop growth retardation and other
skeletal deformities. Although the absence of endogenous
TNAP activity did not result in complete lack of mineral
uptake in skeletal tissues [37], Tnap−/− mice revealed a
severe disturbance of the growth plate, suggesting abnormal
endochondral ossification [39]. It was shown that depletion
of Tnap gene results not only in hypomineralization of the
skeleton, but also in a severe disorder of mineral crystal
alignment in growing long bones with a disordered bone
matrix architecture [40]. Murshed et al. have reported that
transgenic mice expressing Tnap in the dermis showed extra-
cellular mineralization consisting of hydroxyapatite crystals
[41]. Given the evidence, it seems that TNAP activity is
essential for mineralization in bone, but it is still unknown
why the cell membranes with intense TNAP activity in bone
are not identical to those forming matrix vesicles.
Recently, basic research on TNAP provided a promising
tool for clinicians. The FDA approved asfotase alfa (Strensiq)
in 2015 for the treatment of hypophosphatasia caused by a
rare hereditary mutation in the alkaline phosphatase gene.
Patients with either perinatal or infant onset of the disease
who were treated with asfotase alfa showed improvement in
overall survival: 97% patients receiving the drug were alive
at age 1 year compared with 42% of control patients selected
from a natural history study group. Patients with juvenile-
onset hypophosphatasia also experienced improved growth
and bone health compared with patients in a natural history
database [42,43].
3.2. Biological action of ecto-nucleotide
pyrophosphatase/phosphodiesterase 1, ENPP 1 in
bone mineralization
ENPP 1 is a member of the ENPP family of proteins, which
are conserved in vertebrates and hydrolyze pyrophosphate
or phosphodiester bonds in various extracellular compounds
such as nucleotides and phospholipids. ENPP1 is composedPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
of two N-terminal somatomedin B-like domains (SMB1 and
SMB2), a catalytic domain and nuclease-like domain (Fig. 5).
ENPP1 participates in different biological processes through
distinct sets of domains: the catalytic and nuclease-like
E
c
t
bModified from Ref. [44] (Kato et al.).
omains act in bone mineralization, while the SMB-like
omains for insulin signaling. The crystalline structure anal-
sis of ENPP1 suggests that the nucleotides are able to be
ccommodated in a pocket formed by an insertion loop in the
atalytic domain, explaining why ATPs are ENPP1’s preferred
ubstrate [44].
In bone mineralization, ENPP1’s catalytic activity gener-
tes PPi — presumably using extracellular ATPs — and the
esultant PPi inhibits mineralization by binding to incipi-
nt hydroxyapatite crystals and preventing their overgrowth
45—47] (Fig. 6). In our observations, ENPP1 immunore-
ctivity was seen throughout the cytoplasm and on the
ecretory (osteoidal) pole of mature osteoblasts, as well as
n osteocytes (data not shown). The localization of ENPP1
redominantly on the osteoidal surface of osteoblasts may
uggest that it inhibits the overgrowth of mineral crystals.
he histological evidence that TNAP is not intensely local-
zed on the osteoidal surface appears to be consistent with
he distribution of ENPP1 on osteoblasts.
Severe ENPP1 deficiency was recently shown to be
elated to a syndrome of spontaneous infantile arterial and
eriarticular mineralization [48,49]. They suggested that
he PPi generated by ENPP1 activity in vascular smooth
uscle cells and chondrocytes disrupts the growth of
ydroxyapatite crystals. In addition, the linkage of genetic
NPP1 dysfunction to infantile arterial mineralization sug-
ests abnormal PPi metabolism seems to be an important
egulatory factor or inducer of osteoblastic differentiation
n vascular smooth muscle cell.
Mice with Enpp1 gene depletion (Enpp1−/− mice), also
nown as tiptoe walking (ttw/ttw) mice, develop pro-
ressive ankylosing intervertebral and peripheral joint
yperostosis and articular cartilage mineralization [50—54].
ackenzie et al. [54] have recently reported on the details
f the skeletal deformities seen in Enpp1−/− mice: miner-
lization in arteries and in the kidney, ectopic formation
f cartilage in the joints and spine, despite the reduced
irculating calcium and phosphate levels. Also, there was
ypermineralization of the talocrural joint and hypominer-
lization of the femur and tibia with reduced trabecular
umber, trabecular bone volume and trabecular/cortical
hickness. Consistent with the marked increased in fibro-
last growth factor (FGF) 23 mRNA, circulating FGF23 was
ignificantly elevated in Enpp1−/− mice [54].
.3. Putative function of ankylosis protein (ANK)
n pyrophosphate transport in cellstural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
NPP1 can be found not only on the cell surface but also in
ytoplasmic regions, generating PPi in the both regions of
he cell (Fig. 6). Ankylosis protein, ANK, which is encoded
y the mouse progressive ankylosis (Ank) gene, appears to
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Figure 6 Schematic design of matrix vesicle-mediated mineralization.
Matrix vesicles provide adequate micro-circumstance for initiation of mineralization. Membrane transporters and enzymes including
TNAP, ENPP1, annexins, ANK and Pit1 equipped on matrix vesicles play a pivotal role in Ca2+ and PO43− transport into the vesicles.
Phosphatidylserine and so forth in the plasma membrane has a high affinity to produce a stable calcium phosphate—phospholipid
complex associated with the inner leaflet of the vesicle’s membrane. Thereafter, amorphous calcium phosphates develop hydroxya-
patite to form needle-shaped mineral crystals. Many mineral crystals penetrate the vesicles’ membranes to form a globular assembly
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rf numerous mineral crystals, i.e., mineralized nodules.
unction as a multiple-pass, transmembrane PPi-channelling
rotein, allowing PPi molecules to pass through the plasma
embrane from the cytoplasm to the outside of the cell
55,56]. In mice, Ank mRNA is expressed in several tis-
ues including the heart, brain, liver, spleen, lung, muscle
nd kidney, as well as in bone and cartilage such as the
rticular cartilage in the shoulder, elbow, wrist and digits.
ince PPi and its derivatives are naturally potent mineral-
zation inhibitors both in vivo and in vitro, ANK-mediated
egulation of PPi levels provides a room for inhibition of
xcessive mineralization in several tissues [55]. Consider-
ng that infants carrying Ank mutations display a three-
o five-fold decrease in extracellular PPi, the Ank gene
ppears to regulate both intra- and extracellular levels of
n important inhibitor of hydroxyapatite crystal formation
55]. Thus, local PPi production naturally inhibits hydrox-
apatite deposition, blocking undesirable mineralization in
rticular cartilage and other tissues. With loss of ANK activ-
ty, however, extracellular PPi levels attenuate, intracellular
Pi levels rise, and unregulated mineralization takes place.
.4. Ca2+ transport through annexins
atrix metalloproteinase (MMP)-3 [57], TNAP
5,16,17,32,57—60], annexins [61], phospholipase A2,
arbonic anhydrase II and lactate dehydrogenase [62] are
ome of the relevant enzymes and proteins involved in
atrix vesicle-mediated mineralization.
Among these molecules, annexins are Ca2+- and lipid-
inding proteins involved in Ca2+ transport and serving as
on channels in the matrix vesicles (Fig. 6). Three annexinsPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
ere identified in the matrix vesicles: annexin A2, A5 and
6 [63—66]. In the first phase of matrix vesicle-mediated
ineralization, mineral complexes appears on the inner
eaflet of the matrix vesicle’s membrane. The affinity of
d
s
p
ihophatidylserine for Ca2+ is quite strong in the inner leaflet
f the matrix vesicle membrane, which is enriched with
nionic lipids [67,68]. The annexin A5 shows Ca2+-dependent
hosphatidylserine-binding properties and may play a cen-
ral role in mineralization. However, Annexin A5−/− mice
id not demonstrate abnormal skeletal development; thus,
ther annexins could replace the biological functions of
nnexin A5 in knockout mice. Thus, further studies seem to
e necessary to clarify the precise role of annexins during
one mineralization.
. Ultrastructure of collagen mineralization
fter the onset of matrix vesicle-mediated mineralization,
ineralized nodules would contact the surrounding collagen
brils. The collagen fibrils mineralization begins at the point
f contact with mineralized nodules (Fig. 7). There are at
east two theories explaining collagen mineralization: one
s the hole zone theory, and another is the one supporting
hat mineralization takes place along the superhelix of col-
agen fibrils, which are arranged in parallel, but shifted at
ertain intervals. According to the hole zone theory, during
he non-mineralizing phase, the gaps within the collagen
brils are occupied by small proteoglycans such as decorin
nd biglycan. However, after elimination of these proteogly-
ans, extracellular Ca2+ and PO43− fill in the gap to generate
alcium phosphate nuclei and mineralize the collagen fib-
ils. Thus, the initial mineralization begins in the collagen
brils’ ‘‘holes’’.
However, while decorin/biglycan-double knockout mice
evealed osteopenia as a result of impaired GAG-linking totural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
ecorin and biglycan core proteins, mineralization was not
timulated [69]. Still, collagen mineralization based on the
rocess of removal of small proteoglycans may need further
nvestigation. On the other hand, TEM observations demon-
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Figure 7 TEM images of the contact between collagen fibrils and mineralized nodules.
(A) In osteoid, several mineralized nodules (MN) are shown to make contact with surrounding collagen fibrils (Co) (arrows). (B) In
other region, mineralized nodules spread out minerals to neighboring collagen fibrils. Thus, collagen mineralization seems to be
associated with mineralized nodules. In contrast, however, collagen striation (short arrows) do not show any mineral deposition.
(C) At a higher magnification, laddering structures of mineral deposition are parallel to the longitudinal axis of the collagen fibrils,
and the length of mineral crystal seems to be identical to that of superhelix.
re m
i
s
b
h
d
e
fPanel A is from Ref. [74] (Amizuka et al.), and panels B and C a
strated that mineralization spread out from the contact
point of mineralized nodules towards the periphery of colla-
gen fibrils (Fig. 7B and C). This finding suggests that collagen
mineralization is association with mineralized nodules. At
a higher magnification, the spicules of calcium phosphate
crystals are seen on the fibrillar structures identical to the
superheix of collagen fibrils, which indicates that mineralPlease cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
crystals are deposited on the superhelix, which serves as a
scaffold for collagen mineralization.
We also examined mineralization on osteogenic disor-
der shionogi (ODS) rats, which carry a hereditary defect
c
todified from Ref. [73] (Ozawa et al.).
n ascorbic acid synthesis [70]. Fragile, fibrillar collagenous
tructures without evident striation were found in ODS rat
ones, which may be a result of misassembling of the triple
elices of collagenous  -chains secondary to ascorbic acid
eprivation. However, that seemed to bear no effect on min-
ralization: fine needle-shaped mineral crystals extended
rom mineralized nodules, and were apparently bound totural and biochemical aspects of matrix vesicle-mediated
/dx.doi.org/10.1016/j.jdsr.2016.09.002
ollagenous fibrillar structures (Fig. 8).
Taken together, these two postulations (the hole zone
heory and mineralization on the superhelix of collagen fib-
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Figure 8 Matrix vesicles and collagen mineralization in ascorbic acid insufficient circumstance.
In a normal state, TEM observations demonstrate numerous matrix vesicles (A) andmineralized nodules (B). At a higher magnification,
mineral crystals extending from the mineralized nodules ran along the collagen fibrils (B). In an insufficient circumstance of ascorbic
acid, which is necessary for collagen synthesis, TEM observations verified the presence of matrix vesicles and mineralized nodules
(C). At a higher magnification, however, collagen fibrils are shown be very fine, but, the fine mineral crystals from the mineralized
n s (D a
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Rodule extended along fine fibrillar structures of collagen fibril
ll the images are modified from Ref. [70] (Hasegawa et al.).
ils) are both without proper foundations, and therefore,
eed further scientific scrutiny.
. Concluding remarks
atrix vesicle-mediated mineralization causes a series of
rchestrated ultrastructural and biochemical events in
one. To achieve proper mineralization, a variety of mem-
rane transporters and enzymes are put at work in matrix
esicles. Of particular importance is the influx of phosphate
ons into matrix vesicles, which involves a complex interplay
mong ENPP1, ANK, TNAP and Pit1. Mineralized nodules, the
lobular assembly of needle-shaped mineral crystals, are
erived from matrix vesicles and may retain some activity
f those transporters and enzymes. However, crystal growth
s likely regulated by surrounding organic materials prior to
ubsequent collagen mineralization.Please cite this article in press as: Hasegawa T, et al. Ultrastruc
mineralization. Japanese Dental Science Review (2016), http:/
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